Kevin T. Conroy - Feb 29, 2024 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Feb 29, 2024
Transactions value $
-$490,636
Form type
4
Date filed
3/4/2024, 08:38 PM
Previous filing
Feb 28, 2024
Next filing
May 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +18.1K +1.41% $0.00 1.31M Feb 29, 2024 Direct F1
transaction EXAS Common Stock Sale -$491K -8.27K -0.63% $59.32 1.3M Mar 1, 2024 Direct F2, F3
holding EXAS Common Stock 27.9K Feb 29, 2024 Held in 401(k) Plan
holding EXAS Common Stock 21.7K Feb 29, 2024 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Feb 29, 2024 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Feb 29, 2024 Held in Grantor Retained Annuity Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Options Exercise $0 -18.1K -25% $0.00 54.4K Feb 29, 2024 Common Stock 18.1K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 1,392,609 shares, Mr. Conroy also holds, in the aggregate, an additional 683,018 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F4 Each restricted stock unit represents a contingent right to receive one share of common stock.
F5 Represents a restricted stock unit award that partially vested on February 29, 2024. The restricted stock units vest in four equal annual installments from the grant date.